Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke

ConditionChronic Stroke

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-80

SponsorStanford University

About this trial

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.

Eligibility criteria

Qualifiers

Age at the time of enrollment: 18-80 years

Diagnosis of ischemic or hemorrhagic stroke

Disease period of more than 6 months

Mini Mental State Examination of at least 24 points

Disqualifiers

Any significant psychiatric problems, including acute confusional state (delirium), ongoing psychosis, or clinically significant depression

Any current drug or alcohol abuse

History of recurrent or unprovoked seizures

Any neurological disorder treatments that involve intracranial surgery or device implantation

Trial design

Treatments tested in this trial

Active Vibrotactile coordinated reset
Sham vibrotactile coordinated reset

Treatment groups

20 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Stanford University

Lead sponsor

Source ClinicalTrials.gov